Clinical Trial Update: " a Randomized Pilot Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation (ECMO-VA)." [Phase 2]

View source ↗

Summary

Phase 2 randomized pilot study to evaluate nebulized amikacin for Gram-negative bacterial pneumonia in mechanically ventilated patients on extracorporeal membra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumonia, Bacterial, Extracorporeal Membrane Oxygenation | Phase 2 | Status: NOT_YET_RECRUITING